Singulair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
Conditions:   Asthma;   Rhinitis AllergicIntervention:   Drug: MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 WeeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2006 Category: Research Source Type: clinical trials

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
Conditions:   Asthma;   Rhinitis AllergicIntervention:   Drug: MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 WeeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2006 Category: Research Source Type: clinical trials

A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)
Condition:   AsthmaInterventions:   Drug: MK0476; montelukast sodium/Duration of Treatment: 16 weeks;   Drug: Comparator: placebo / Duration of Treatment: 16 weeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2005 Category: Research Source Type: clinical trials

A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)
Condition:   AsthmaInterventions:   Drug: MK0476; montelukast sodium;   Drug: Comparator: placeboSponsor:   Merck Sharp & Dohme Corp.Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2005 Category: Research Source Type: clinical trials

A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)
Condition:   AsthmaInterventions:   Drug: MK0476; montelukast sodium/Duration of Treatment: 16 weeks;   Drug: Comparator: placebo / Duration of Treatment: 16 weeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2005 Category: Research Source Type: clinical trials